Article in American journal of physiology. Renal physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Chelsea C EstradaDivision of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York, United States.ORCID 0000-0002-3249-045X
Craig WilsonDivision of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York, United States.
Nehaben GujaratiDivision of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York, United States.
Sumaya AhmedDivision of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York, United States.
Robert BronsteinDivision of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York, United States.
Ilse S DaehnDivision of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States.
Monica P ReveloDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States.ORCID 0000-0002-5746-408X
Yiqing GuoDivision of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York, United States.
Sandeep K MallipattuDivision of Nephrology, Department of Medicine, Stony Brook University, Stony Brook, New York, United States.ORCID 0000-0002-6324-7807
Funding
Glomerular Cell-Cell Crosstalk and InjuryR01DK097253 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAEHN, ILSE SOFIA · 2013 to 2025
$7.3M
Transcriptional control of mitochondrial function by KLF6 in diabetic kidney diseaseR01DK112984 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI Sandeep K Mallipattu · 2017 to 2026
$3.5M
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathiesR01DK121846 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI HE, JOHN CIJIANG, MALLIPATTU, SANDEEP K · 2020 to 2024
$2.7M
Genetic risk and molecular characterization of Diabetic Kidney DiseaseR01DK139395 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ilse Sofia Daehn · 2024 to 2026
$1.0M
BLRD VA I01 BX003698BLRD VA I01 BX005300BLRD VA IK2 BX005380Dialysis Clinics (DCI)HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK112984HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK121846NIDDK NIH HHS R01 DK097253NIDDK NIH HHS R01 DK112984NIDDK NIH HHS R01 DK121846NIDDK NIH HHS R01 DK139395U.S. Department of Veterans Affairs (VA) 1I01BX003698U.S. Department of Veterans Affairs (VA) 1I01BX005300U.S. Department of Veterans Affairs (VA) 5IK2BX005380
6 · The paper itself
Abstract
Glomerular endothelial cell (GEnC) injury is a common feature across the wide spectrum of glomerular diseases. We recently reported that the endothelial-specific knockout of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Induction of plasmalemmal vesicle-associated protein exacerbates glomerular endothelial injury in thrombotic microangiopathy. · full record | OpenQuestion